Immuron Submits IND Application To FDA For Travelan

Investigational New Drug (IND) application submitted to the U.S. Food and Drug administration (FDA) Plans in place to initiate a Human clinical trial in 60 healthy volunteers in the USA Clinical Trial to examine a
  • Investigational New Drug (IND) application submitted to the U.S. Food and Drug administration (FDA)
  • Plans in place to initiate a Human clinical trial in 60 healthy volunteers in the USA
  • Clinical Trial to examine a dosing regimen for Travelan more suited for use by the US military
    • Infectious diarrhea is the most common illness reported by travelers
Total
0
Shares
Related Posts